CH621876A5 - - Google Patents

Download PDF

Info

Publication number
CH621876A5
CH621876A5 CH534276A CH534276A CH621876A5 CH 621876 A5 CH621876 A5 CH 621876A5 CH 534276 A CH534276 A CH 534276A CH 534276 A CH534276 A CH 534276A CH 621876 A5 CH621876 A5 CH 621876A5
Authority
CH
Switzerland
Prior art keywords
hcg
coupling agent
globulin
composition
serum
Prior art date
Application number
CH534276A
Other languages
German (de)
English (en)
Inventor
Lea Grundman
Original Assignee
Rafa Labor Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rafa Labor Ltd filed Critical Rafa Labor Ltd
Publication of CH621876A5 publication Critical patent/CH621876A5/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y10S530/816—Attached to the carrier via a bridging agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CH534276A 1975-05-02 1976-04-28 CH621876A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL47223A IL47223A (en) 1975-05-02 1975-05-02 Method for the determination of pregnancy and serodiagnostic composition therefor

Publications (1)

Publication Number Publication Date
CH621876A5 true CH621876A5 (fr) 1981-02-27

Family

ID=11048219

Family Applications (1)

Application Number Title Priority Date Filing Date
CH534276A CH621876A5 (fr) 1975-05-02 1976-04-28

Country Status (16)

Country Link
US (1) US4088749A (fr)
JP (1) JPS51133416A (fr)
AT (1) AT351174B (fr)
AU (1) AU503343B2 (fr)
BE (1) BE841172A (fr)
CA (1) CA1050424A (fr)
CH (1) CH621876A5 (fr)
DE (1) DE2618449A1 (fr)
ES (1) ES447474A1 (fr)
FI (1) FI761207A (fr)
FR (1) FR2309867A1 (fr)
GB (1) GB1516591A (fr)
IL (1) IL47223A (fr)
IT (1) IT1061499B (fr)
NL (1) NL7604637A (fr)
ZA (1) ZA762527B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1146852A (fr) * 1979-01-31 1983-05-24 Koichi Kondo Reactif d'agglutination du latex
IL63855A (en) * 1981-09-16 1984-10-31 Teva Pharma Method and kit for detecting pregnancy
US4543339A (en) * 1982-03-16 1985-09-24 Oneill Christopher Early pregnancy detection by detecting enhanced blood platelet activation
DE3210080A1 (de) * 1982-03-19 1983-09-22 Behringwerke Ag, 3550 Marburg Anti-streptolysin o-latex-reagenz und verfahren zu seiner herstellung
JPS61247966A (ja) * 1985-04-25 1986-11-05 Daikin Ind Ltd 抗原−抗体反応測定用試薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125235C (fr) * 1965-04-15
US3639558A (en) * 1968-02-19 1972-02-01 Louis Csizmas Immunological reagent particles having proteinaceous materials covalently bonded thereto
US3882225A (en) * 1968-12-09 1975-05-06 Miles Lab Direct agglutination immunological reagent
US3951748A (en) * 1974-11-11 1976-04-20 Medical Products, Inc. Sensitized matrix for detection of disease

Also Published As

Publication number Publication date
DE2618449A1 (de) 1977-03-31
FI761207A (fr) 1976-11-03
AU503343B2 (en) 1979-08-30
IT1061499B (it) 1983-02-28
ES447474A1 (es) 1977-07-01
JPS51133416A (en) 1976-11-19
BE841172A (fr) 1976-10-27
NL7604637A (nl) 1976-11-04
ATA313476A (de) 1978-12-15
IL47223A (en) 1979-01-31
IL47223A0 (en) 1975-07-28
ZA762527B (en) 1977-04-27
GB1516591A (en) 1978-07-05
FR2309867B1 (fr) 1981-10-30
FR2309867A1 (fr) 1976-11-26
AU1356676A (en) 1977-11-10
CA1050424A (fr) 1979-03-13
AT351174B (de) 1979-07-10
US4088749A (en) 1978-05-09

Similar Documents

Publication Publication Date Title
DE2651139C3 (de) Reagens zur Durchführung eines Direktagglutinationstests zum Schwangerschaftsnachweis und Verfahren zu seiner Herstellung
DE1598832A1 (de) Auf der Beobachtung eines Agglutinationsvorganges beruhendes Verfahren zum Nachweis von Choriongonadotropin in Koerperfluessigkeiten
DE1005759B (de) Zur Bestimmung von Blutgruppen verwendbare Karte
DE3002973C2 (fr)
DE2551208A1 (de) Stabile erythrozyten-praeparation, verfahren zu deren herstellung und deren verwendung
DE2653032A1 (de) Radioimmun-nachweisverfahren fuer ein schilddruesenhormon und dafuer geeignetes reagens
DE1192367B (de) Verfahren zur Herstellung eines immunologischen Reagens
DE3105555C2 (fr)
DE2710264B2 (de) Verfahren zur Bestimmung und Analyse eines Immunkomplexes
DE602004012161T2 (de) Verkürzung der zeit bis zum vorliegen von blutbankdiagnostikergebnissen
CH621876A5 (fr)
DE2934757C2 (de) Zusammensetzung und Verfahren zur Bestimmung von Humanimmunglobulin-G
DE2463435C2 (de) Vorrichtung zur Durchführung eines Verfahrens zum Nachweisen von Proteinen und Antikörpern
DE1617734B1 (de) Verfahren zur Herstellung eines immunologischen Reagens
DE2934756A1 (de) Zusammensetzung zur bestimmung von beta 2 -humanmikroglobulin und verfahren zu deren herstellung und deren verwendung
DE2551576A1 (de) Traeger fuer immunochemische messungen
DE69332764T2 (de) Hydroxylamin enthaltendes kontrollreagenz
DE2054805A1 (de) Indirekter Hamagglutmationstest bei gleichzeitiger Adsorption heterologer Antikörper
EP0011716A1 (fr) Réactif pour la détermination de mononucléose infectieuse et procédé pour sa préparation
DE2023989B2 (de) Verfahren zur Herstellung von aus Antigen Tragerstoffgemischen bestehenden und gegebenenfalls Antikörper enthalten den fertigen serodiagnostischen, auf einen Objektträger aufgebrachten lager bestandigen Testsubstanzen
DE1598928A1 (de) Verfahren zum Nachweis der infektioesen Mononukleose und Nachweisreagenz
EP0034301A2 (fr) Procédé pour la détermination des complexes immunologiques
DE2243237A1 (de) Nachweis der immunreaktion gegenueber krebs
DE2633248A1 (de) Serumdiagnostische zusammensetzung
DD214000A5 (de) Verfahren zur bestimmung von igg

Legal Events

Date Code Title Description
PL Patent ceased